SOUTHBOROUGH, MA – May 29, 2024 – Veristat, the Science-First Full Service CRO and Consultancy, is pleased to announce that Gabriela Rosu, M.D., has joined as Senior Director, Global Medical Affairs.
Veristat Welcomes Three New Leaders to Executive Team, Driving Global Growth and Regulatory Success in Clinical Research
Veristat Delivered a Full Range of Clinical Trial Services Culminating in Marketing Authorization of HIPRA’s SARS-CoV-2 Vaccine and...
Supporting Its Continued Commitment During Rare Disease Month to Making a Difference in the Lives of Patients Faced with Limited Treatment...
Highlights the unique advantages its DCT solutions hold for small to mid-size biotechs conducting trials for complex diseases